Guthrie Foundation Offers Study of Antiplatelet Drugs for PAD Patients

Guthrie Foundation has announced that the following clinical study is open to enrollment at the Sayre Campus: A randomized, double-blind, parallel group, multicenter phase IIIb study to compare two antiplatelet study drugs on the risk of cardiovascular death, myocardial infarction and ischemic stroke in patients with established Peripheral Artery Disease, sponsored by AstraZeneca. The principal investigator is Dr. Robert Larson, and the research coordinator is Donna Tyburczy, RN.

For information or to enroll a patient, call 570-887-6071.